The p53 tumor suppressor gene in ductal carcinoma in situ of the breast

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 5-6

  Simpson, J F ^a   Page, D L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

BREAST CARCINOMA; CANCER GENETICS; CANCER INVASION; GENE MUTATION; HUMAN; NOTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033870868     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64698-6     Document Type: Note

References (12)

1. p53 Mutations and expression in breast carcinoma in situ
2. Maintenance of p53 alterations throughout breast cancer progression
3. p53 Mutations are confined to the comedo type ductal carcinoma in situ of the breast: Immunohistochemical and sequencing data
4. p53 Mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade
5. Ductal carcinoma in situ of the breast: A new model
6. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
7. Intraductal carcinoma: Long-term follow-up after treatment by biopsy alone
8. Ductal carcinoma in situ: The focus for prevention, screening, and breast conservation in breast cancer
9. Heterogeneity of intraductal carcinoma of the breast
10. Ductal carcinoma in situ of the breast: Heterogeneity of individual lesions
11. Incidence of and treatment for ductal carcinoma in situ of the breast
12. Prognostic and predictive value of p53 and p21 in breast cancer